Literature DB >> 20513781

Use of antidepressants during pregnancy and the risk of spontaneous abortion.

Hamid Reza Nakhai-Pour1, Perrine Broy, Anick Bérard.   

Abstract

BACKGROUND: The risk of relapse of depression or the diagnosis of some other psychiatric disorders during pregnancy necessitates the use of antidepressants despite possible adverse effects. Whether such use increases the risk of spontaneous abortion is still being debated. We evaluated the risk of spontaneous abortion in relation to the use of antidepressants during pregnancy.
METHODS: Using a nested case-control study design, we obtained data from the Quebec Pregnancy Registry for 5124 women who had a clinically detected spontaneous abortion. For each case, we randomly selected 10 controls from the remaining women in the registry who were matched by the case's index date (date of spontaneous abortion) and gestational age at the time of spontaneous abortion. Use of antidepressants was defined by filled prescriptions and was compared with nonuse. We also studied the classes, types and doses of antidepressants.
RESULTS: A total of 284 (5.5%) of the women who had a spontaneous abortion had at least one prescription for an antidepressant filled during the pregnancy, as compared with 1401 (2.7%) of the matched controls (odds ratio [OR] 2.09, 95% confidence interval [CI] 1.83-2.38). After adjustment for potential confounders, we found that the use of antidepressants during pregnancy was associated with an increased risk of spontaneous abortion (OR 1.68, 95%CI 1.38-2.06). Stratified analyses showed that use of selective serotonin reuptake inhibitors alone (OR 1.61, 95% CI 1.28-2.04), serotonin-norepinephrine reuptake inhibitors alone (OR 2.11, 95% CI 1.34-3.30) and combined use of antidepressants from different classes (OR 3.51, 95% CI 2.20-5.61) were associated with an increased risk of spontaneous abortion. When we looked at antidepressant use by type versus no use, paroxetine use alone (OR 1.75, 95% CI 1.31-2.34) and venlafaxine use alone (OR 2.11, 95% CI 1.34-3.30) were associated with an increased risk of spontaneous abortion.
INTERPRETATION: The use of antidepressants, especially paroxetine, venlafaxine or the combined use of different classes of antidepressants, during pregnancy was associated with an increased risk of spontaneous abortion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513781      PMCID: PMC2900326          DOI: 10.1503/cmaj.091208

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  28 in total

Review 1.  Epidemiology and the medical causes of miscarriage.

Authors:  L Regan; R Rai
Journal:  Baillieres Best Pract Res Clin Obstet Gynaecol       Date:  2000-10

2.  Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.

Authors:  A Einarson; B Fatoye; M Sarkar; S V Lavigne; J Brochu; C Chambers; P Mastroiacovo; A Addis; D Matsui; L Schuler; T R Einarson; G Koren
Journal:  Am J Psychiatry       Date:  2001-10       Impact factor: 18.112

Review 3.  The nested case-control study in cardiology.

Authors:  Vidal Essebag; Jacques Genest; Samy Suissa; Louise Pilote
Journal:  Am Heart J       Date:  2003-10       Impact factor: 4.749

4.  Delivery outcome after the use of antidepressants in early pregnancy.

Authors:  A Ericson; B Källén; B Wiholm
Journal:  Eur J Clin Pharmacol       Date:  1999-09       Impact factor: 2.953

5.  First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

Authors:  Anick Bérard; Elodie Ramos; Evelyne Rey; Lucie Blais; Martin St-André; Driss Oraichi
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2007-02

6.  Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.

Authors:  Josephine Djulus; Gideon Koren; Thomas R Einarson; Lynda Wilton; Saad Shakir; Orna Diav-Citrin; Deborah Kennedy; Sharon Voyer Lavigne; Marco De Santis; Adrienne Einarson
Journal:  J Clin Psychiatry       Date:  2006-08       Impact factor: 4.384

7.  Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

Authors:  Lee S Cohen; Lori L Altshuler; Bernard L Harlow; Ruta Nonacs; D Jeffrey Newport; Adele C Viguera; Rita Suri; Vivien K Burt; Victoria Hendrick; Alison M Reminick; Ada Loughead; Allison F Vitonis; Zachary N Stowe
Journal:  JAMA       Date:  2006-02-01       Impact factor: 56.272

8.  Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.

Authors:  Brian Chun-Fai-Chan; Gideon Koren; Ibrahim Fayez; Sanjog Kalra; Sharon Voyer-Lavigne; Andrew Boshier; Saad Shakir; Adrienne Einarson
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

9.  Psychosocial predictors of successful delivery after unexplained recurrent spontaneous abortions: a cohort study.

Authors:  Y Nakano; M Oshima; M Sugiura-Ogasawara; K Aoki; T Kitamura; T A Furukawa
Journal:  Acta Psychiatr Scand       Date:  2004-06       Impact factor: 6.392

Review 10.  Prevalence of depression during pregnancy: systematic review.

Authors:  Heather A Bennett; Adrienne Einarson; Anna Taddio; Gideon Koren; Thomas R Einarson
Journal:  Obstet Gynecol       Date:  2004-04       Impact factor: 7.661

View more
  34 in total

1.  Spontaneous abortion and NSAIDs.

Authors:  Christine A Clark; Karen A Spitzer; Carl A Laskin; Gideon Koren
Journal:  CMAJ       Date:  2011-12-13       Impact factor: 8.262

Review 2.  Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues.

Authors:  Luke E Grzeskowiak; Andrew L Gilbert; Janna L Morrison
Journal:  Drug Saf       Date:  2011-11-01       Impact factor: 5.606

3.  Antidepressants and pregnancy: complexities of producing evidence-based information.

Authors:  Adrienne Einarson
Journal:  CMAJ       Date:  2010-05-31       Impact factor: 8.262

4.  Antidepressant use (during pregnancy) and miscarriage.

Authors:  Anick Bérard; Hamid Reza Nakhai-Pour; Perrine Broy
Journal:  CMAJ       Date:  2010-07-13       Impact factor: 8.262

5.  Antidepressants and pregnancy.

Authors:  Barbara Mintzes; Elia Abi-Jaoude; Anne Rochon Ford
Journal:  CMAJ       Date:  2011-03-22       Impact factor: 8.262

6.  Antidepressants and spontaneous abortion.

Authors:  Don Lint
Journal:  CMAJ       Date:  2011-08-09       Impact factor: 8.262

7.  Antidepressants and spontaneous abortion.

Authors:  Anick Bérard
Journal:  CMAJ       Date:  2011-08-09       Impact factor: 8.262

8.  Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion.

Authors:  Hamid Reza Nakhai-Pour; Perrine Broy; Odile Sheehy; Anick Bérard
Journal:  CMAJ       Date:  2011-09-06       Impact factor: 8.262

Review 9.  Antidepressant use in pregnancy: a critical review focused on risks and controversies.

Authors:  N Byatt; K M Deligiannidis; M P Freeman
Journal:  Acta Psychiatr Scand       Date:  2012-12-14       Impact factor: 6.392

10.  Safety of treatment of obsessive compulsive disorder in pregnancy and puerperium.

Authors:  Shirin Namouz-Haddad; Irena Nulman
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.